Geron (MM)
   
To register click here

Geron Stock Price GERN

Company Description : A biopharmaceutical company, which is developing therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. url: www.geron.com

Name:
Geron (MM)
Symbol:
NASDAQ:GERN
Stock Market:
NASDAQ Stock Market
Type:
Common Stock
ISIN:
Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
0.112.584.374.244.684.494.254.2954739216:41:25
To register Click hereRegister for free Geron stock prices.

Geron: Embryonic stem cell therapy for heart failure evades immune system attack : NEW YORK (Thomson Financial) - Shares of Geron Corp. rose in early trading Thursday after the company said it has research studies that show its human embryonic stem cell-based therapy for the treatment of heart failure...

Free Geron Stock Charts

Geron Historical Stock Chart
Geron Historical Stock Chart
Geron Monthly Stock Chart
Geron Monthly Stock Chart
Geron Intraday stock chart
Geron Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest Geron stock Price, quotes, trades and FREE Geron stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Geron (GERN) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Geron News & Message Board Discussion

Latest Geron News Headlines
DateTimeSource
Headline
06/12/20089:56AMTFNFGeron: Embryonic stem cell therapy for heart failure evades immune system attack
05/14/20083:07PMTFNFFDA places Geron's spinal cord injury treatment submission on clinical hold
01/16/200810:15AMPRNUSStart Licensing, Inc. Welcomes FDA's Finding of Safety of Food From Cloned Animals
12/12/20072:16PMTFNFGeron gets Merck payment for study plans
12/12/20078:25AMTFNFGeron receives $4 million payment from Merck licensing agreement
Latest Message Board Discussions
DateTimeSource
TitleMore
04/03/20072:54PMFreeGeron stem cell patent 
02/12/20042:34PMFreeGERON....A stock for the 21st Century 

Geron Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Geron company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Geron Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
  800 4.4025 07/25/2008 4:02PM USD


 



PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
31 site:2us nasdaq gern080725 19:01 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )